Articles

Results 1 to 5 of 6
Most popular |Most recent


At a glance: pharmaceutical merger review in Norway

Norway - June 30 2020 This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in Norway, including review triggers and thresholds.

Eivind J Vesterkjær.

Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in Norway

Norway - June 30 2020 A look at key practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in Norway, including IP rights abuse and pricing conduct.

Eivind J Vesterkjær.

In brief: anticompetitive agreements in the pharmaceutical sector in Norway

Norway - June 30 2020 The essential legal considerations surrounding anticompetitive agreements in the pharmaceutical sector in Norway, including the assessment framework and special issues with vertical agreements.

Eivind J Vesterkjær.

Anticompetitive unilateral conduct in the pharmaceutical sector in Norway

Norway - September 6 2019 An overview of practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in Norway, including IP rights abuse and pricing conduct.

Eivind J Vesterkjær.

Pharmaceutical antitrust law in Norway

Norway - September 6 2019 A structured guide to antitrust law in the pharmaceutical sector in Norway, including the legislative and regulatory framework, merger review, anticompetitive agreements and abuse of dominance.

Eivind J Vesterkjær.